Short-term and long-term oncological outcomes of chemoradiotherapy for rectal cancer patients with or without oxaliplatin: a propensity score-matched retrospective analysis

HIGHLIGHTS

• What: Ethics statement This study design was approved by the institutional review board (code: 1401-4-417-63804) and the ethics committee of Tehran University of Medical Sciences (IR.TUMS.IKHC.REC.1401.397). This study was conducted in accordance with the principles outlined in the Declaration of Helsinki. Before their inclusion in the study, all patients had provided written informed consent regarding the use of their personal data for research purposes upon admission.
• Who: Azimi et_al Radiation Oncology and collaborators from the This study design was approved by the institutional review board (code:, ) and . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.